Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Team Creative Environment as a Mediator Between CWX and R&D Team Performance and Moderating Boundary Conditions.

Bornay-Barrachina M, Herrero I.

J Bus Psychol. 2018;33(2):311-323. doi: 10.1007/s10869-017-9495-8. Epub 2017 Apr 5.

2.

Subclinical Antibody-Mediated Rejection.

Arias M, Serón D, Herrero I, Rush DN, Wiebe C, Nickerson PW, Ussetti P, Rodrigo E, de Cos MA.

Transplantation. 2017 Jun;101(6S Suppl 1):S1-S18. doi: 10.1097/TP.0000000000001735. No abstract available.

PMID:
28538291
3.

Totally Laparoscopic Right Hepatectomy for Living Donor Liver Transplantation: Analysis of a Preliminary Experience on 5 Consecutive Cases.

Rotellar F, Pardo F, Benito A, Zozaya G, Martí-Cruchaga P, Hidalgo F, Lopez L, Iñarrairaegui M, Sangro B, Herrero I.

Transplantation. 2017 Mar;101(3):548-554. doi: 10.1097/TP.0000000000001532.

PMID:
27755505
4.

Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients.

Pascual J, Royuela A, Fernández AM, Herrero I, Delgado JF, Solé A, Guirado L, Serrano T, de la Torre-Cisneros J, Moreno A, Cordero E, Gallego R, Lumbreras C, Aguado JM; Spanish Society of Transplantation Virological and Immune Response Investigation Study Group.

Transpl Infect Dis. 2016 Dec;18(6):819-831. doi: 10.1111/tid.12601. Epub 2016 Oct 19. Review.

PMID:
27600985
5.

Controlling Diabetes After Liver Transplantation: Room for Improvement.

Alvarez-Sotomayor D, Satorres C, Rodríguez-Medina B, Herrero I, de la Mata M, Serrano T, Rodríguez-Perálvarez M, DʼAvola D, Lorente S, Rubín A, Berenguer M.

Transplantation. 2016 Oct;100(10):e66-e73.

PMID:
27653229
6.

Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency: Database Evaluation and Population Analysis.

Lara B, Blanco I, Martínez MT, Rodríguez E, Bustamante A, Casas F, Cadenas S, Hernández JM, Lázaro L, Torres M, Curi S, Esquinas C, Dasí F, Escribano A, Herrero I, Martínez-Delgado B, Michel FJ, Rodríguez-Frías F, Miravitlles M.

Arch Bronconeumol. 2017 Jan;53(1):13-18. doi: 10.1016/j.arbres.2016.05.003. Epub 2016 Jun 17. English, Spanish.

7.

First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study.

Martínez-Calle N, Alfonso A, Rifón J, Herrero I, Errasti P, Rábago G, Merino J, Panizo Á, Pardo J, Prósper F, García-Muñoz R, Lecumberri R, Panizo C.

Eur J Haematol. 2017 Jan;98(1):38-43. doi: 10.1111/ejh.12782. Epub 2016 Jun 28.

PMID:
27232286
8.

Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.

Torre-Cisneros J, Aguado JM, Caston JJ, Almenar L, Alonso A, Cantisán S, Carratalá J, Cervera C, Cordero E, Fariñas MC, Fernández-Ruiz M, Fortún J, Frauca E, Gavaldá J, Hernández D, Herrero I, Len O, Lopez-Medrano F, Manito N, Marcos MA, Martín-Dávila P, Monforte V, Montejo M, Moreno A, Muñoz P, Navarro D, Pérez-Romero P, Rodriguez-Bernot A, Rumbao J, San Juan R, Vaquero JM, Vidal E; Spanish Society of Transplantation (SET); Group for Study of Infection in Transplantation of the Spanish Society of Infectious Diseases and Clinical Microbiology (GESITRA-SEIMC); Spanish Network for Research in Infectious Diseases (REIPI).

Transplant Rev (Orlando). 2016 Jul;30(3):119-43. doi: 10.1016/j.trre.2016.04.001. Epub 2016 Apr 29. Review.

PMID:
27132815
9.

Factors related to increased resting energy expenditure in men with liver cirrhosis.

Prieto-Frías C, Conchillo M, Payeras M, Iñarrairaegui M, Davola D, Frühbeck G, Salvador J, Rodríguez M, Richter JÁ, Mugueta C, Gil MJ, Herrero I, Prieto J, Sangro B, Quiroga J.

Eur J Gastroenterol Hepatol. 2016 Feb;28(2):139-45. doi: 10.1097/MEG.0000000000000516.

PMID:
26560751
10.

Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation.

Caston JJ, Castells L, Varo E, Gomez MA, de la Mata M, Campos-Varela I, Lumbreras C, Gonzalez-Dieguez L, Fabregat J, Herrero I, Salcedo M, Sanchez-Antolín G, Torre-Cisneros J.

Transplantation. 2016 Mar;100(3):593-9. doi: 10.1097/TP.0000000000000912. Erratum in: Transplantation. 2017 Jan;101(1):e40.

PMID:
26371595
11.

In vivo horizontal dissemination of the blaKPC-2 gene carried on diverse genetic platforms among clinical isolates of Enterobacteriaceae.

Anchordoqui MS, De Belder D, Lucero C, Rapoport M, Faccone D, Rodriguez A, Di Martino A, Martino F, Herrero I, Pasteran F, Corso A, Gomez SA.

J Glob Antimicrob Resist. 2015 Sep;3(3):210-213. doi: 10.1016/j.jgar.2015.05.001. Epub 2015 Jun 6.

PMID:
27873711
12.

Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain.

Bilbao I, Salcedo M, Gómez MA, Jimenez C, Castroagudín J, Fabregat J, Almohalla C, Herrero I, Cuervas-Mons V, Otero A, Rubín A, Miras M, Rodrigo J, Serrano T, Crespo G, De la Mata M, Bustamante J, Gonzalez-Dieguez ML, Moreno A, Narvaez I, Guilera M; EVEROLIVER study group.

Liver Transpl. 2015 Aug;21(8):1056-65. doi: 10.1002/lt.24172.

13.

Totally laparoscopic right-lobe hepatectomy for adult living donor liver transplantation: useful strategies to enhance safety.

Rotellar F, Pardo F, Benito A, Martí-Cruchaga P, Zozaya G, Lopez L, Hidalgo F, Sangro B, Herrero I.

Am J Transplant. 2013 Dec;13(12):3269-73. doi: 10.1111/ajt.12471. Epub 2013 Oct 8.

14.

[Orthotopic liver transplantation in polycystic liver disease].

Arredondo J, Rotellar F, Herrero I, Pedano N, Martí P, Zozaya G, Bellver M, Pardo F.

Cir Esp. 2013 Dec;91(10):659-63. doi: 10.1016/j.ciresp.2012.11.010. Epub 2013 Feb 27. Spanish.

PMID:
23453022
15.

Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.

Reboredo M, Chang HC, Barbero R, Rodríguez-Ortigosa CM, Pérez-Vizcaíno F, Morán A, García M, Banales JM, Carreño N, Alegre F, Herrero I, Quiroga J, Prieto J, Sangro B.

PLoS One. 2013;8(1):e52683. doi: 10.1371/journal.pone.0052683. Epub 2013 Jan 16.

16.

Case-based reasoning emulation of persons for wheelchair navigation.

Peula JM, Urdiales C, Herrero I, Fernandez-Carmona M, Sandoval F.

Artif Intell Med. 2012 Oct;56(2):109-21. doi: 10.1016/j.artmed.2012.08.007. Epub 2012 Oct 13.

PMID:
23068883
17.

Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation.

Gomez-Martin C, Bustamante J, Castroagudin JF, Salcedo M, Garralda E, Testillano M, Herrero I, Matilla A, Sangro B.

Liver Transpl. 2012 Jan;18(1):45-52. doi: 10.1002/lt.22434.

18.

Differential in vitro and in vivo effect of barley cysteine and serine protease inhibitors on phytopathogenic microorganisms.

Carrillo L, Herrero I, Cambra I, Sánchez-Monge R, Diaz I, Martinez M.

Plant Physiol Biochem. 2011 Oct;49(10):1191-200. doi: 10.1016/j.plaphy.2011.03.012. Epub 2011 Mar 31.

PMID:
21482127
19.

The effect of L-alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients.

Grau T, Bonet A, Miñambres E, Piñeiro L, Irles JA, Robles A, Acosta J, Herrero I, Palacios V, Lopez J, Blesa A, Martínez P; Metabolism, Nutrition Working Group, SEMICYUC, Spain.

Crit Care Med. 2011 Jun;39(6):1263-8. doi: 10.1097/CCM.0b013e31820eb774.

PMID:
21336131
20.

Treatment of murine fulminant hepatitis with genetically engineered endothelial progenitor cells.

Fernandez-Ruiz V, Kawa M, Berasain C, Iñiguez M, Schmitz V, Martinez-Ansó E, Iñarrairaegui M, Herrero I, Sangro B, D'Avola D, Quiroga J, Qian C, Prieto J.

J Hepatol. 2011 Oct;55(4):828-37. doi: 10.1016/j.jhep.2011.01.036. Epub 2011 Feb 18.

PMID:
21334399
21.

[Truancy in the wave of the epidemic in 2009-2010 influenza season schools of the city of Ceuta, Spain].

Barrientos MD, Toledo A, Rivas AI, Medina M, Padilla I, Herrero I.

Rev Esp Salud Publica. 2010 Sep-Oct;84(5):679-85. Spanish.

22.

Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection.

Riezu-Boj JI, Larrea E, Aldabe R, Guembe L, Casares N, Galeano E, Echeverria I, Sarobe P, Herrero I, Sangro B, Prieto J, Lasarte JJ.

J Hepatol. 2011 Mar;54(3):422-31. doi: 10.1016/j.jhep.2010.07.014. Epub 2010 Sep 26.

PMID:
21129807
23.

A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma.

Sangro B, Mazzolini G, Ruiz M, Ruiz J, Quiroga J, Herrero I, Qian C, Benito A, Larrache J, Olagüe C, Boan J, Peñuelas I, Sádaba B, Prieto J.

Cancer Gene Ther. 2010 Dec;17(12):837-43. doi: 10.1038/cgt.2010.40. Epub 2010 Aug 6.

PMID:
20689572
24.

Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.

Sangro B, Bilbao JI, Boan J, Martinez-Cuesta A, Benito A, Rodriguez J, Panizo A, Gil B, Inarrairaegui M, Herrero I, Quiroga J, Prieto J.

Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):792-800. Epub 2006 Aug 14.

PMID:
16904840
25.

Vancomycin-resistant Enterococcus faecium clone in swine, Europe.

Novais C, Coque TM, Boerlin P, Herrero I, Moreno MA, Dominguez L, Peixe L.

Emerg Infect Dis. 2005 Dec;11(12):1985-7. No abstract available.

26.

Occurrence and relatedness of vancomycin-resistant enterococci in animals, humans, and the environment in different European regions.

Kühn I, Iversen A, Finn M, Greko C, Burman LG, Blanch AR, Vilanova X, Manero A, Taylor H, Caplin J, Domínguez L, Herrero IA, Moreno MA, Möllby R.

Appl Environ Microbiol. 2005 Sep;71(9):5383-90.

27.

New aspect of the synergistic antibacterial action of ampicillin and gentamicin.

Barnes AI, Herrero IL, Albesa I.

Int J Antimicrob Agents. 2005 Aug;26(2):146-51.

PMID:
16024233
28.
29.

The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.

Rios R, Sangro B, Herrero I, Quiroga J, Prieto J.

Am J Gastroenterol. 2005 Jun;100(6):1311-6.

PMID:
15929762
30.

Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas.

Mazzolini G, Alfaro C, Sangro B, Feijoó E, Ruiz J, Benito A, Tirapu I, Arina A, Sola J, Herraiz M, Lucena F, Olagüe C, Subtil J, Quiroga J, Herrero I, Sádaba B, Bendandi M, Qian C, Prieto J, Melero I.

J Clin Oncol. 2005 Feb 10;23(5):999-1010. Epub 2004 Dec 14.

PMID:
15598979
31.

Dynamic color Doppler sonography of intestinal wall in patients with Crohn disease compared with healthy subjects.

Scholbach T, Herrero I, Scholbach J.

J Pediatr Gastroenterol Nutr. 2004 Nov;39(5):524-8.

PMID:
15572893
32.

Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors.

Sangro B, Mazzolini G, Ruiz J, Herraiz M, Quiroga J, Herrero I, Benito A, Larrache J, Pueyo J, Subtil JC, Olagüe C, Sola J, Sádaba B, Lacasa C, Melero I, Qian C, Prieto J.

J Clin Oncol. 2004 Apr 15;22(8):1389-97.

PMID:
15084613
33.

Dogs should be included in surveillance programs for vancomycin-resistant enterococci.

Herrero IA, Fernández-Garayzábal JF, Moreno MA, Domínguez L.

J Clin Microbiol. 2004 Mar;42(3):1384-5. No abstract available.

34.

Management objective importance in fisheries: an evaluation using the analytic hierarchy process (AHP).

Mardle S, Pascoe S, Herrero I.

Environ Manage. 2004 Jan;33(1):1-11. Epub 2004 Feb 24.

PMID:
14994158
35.

Comparison of enterococcal populations in animals, humans, and the environment--a European study.

Kühn I, Iversen A, Burman LG, Olsson-Liljequist B, Franklin A, Finn M, Aarestrup F, Seyfarth AM, Blanch AR, Vilanova X, Taylor H, Caplin J, Moreno MA, Dominguez L, Herrero IA, Möllby R.

Int J Food Microbiol. 2003 Dec 1;88(2-3):133-45.

PMID:
14596986
36.

Reevaluation of Streptococcus bovis endocarditis cases from 1975 to 1985 by 16S ribosomal DNA sequence analysis.

Herrero IA, Rouse MS, Piper KE, Alyaseen SA, Steckelberg JM, Patel R.

J Clin Microbiol. 2002 Oct;40(10):3848-50. Erratum in: J Clin Microbiol. 2003 Feb;41(2):916..

37.

Antimicrobial resistance among enterococci from pigs in three European countries.

Aarestrup FM, Hasman H, Jensen LB, Moreno M, Herrero IA, Domínguez L, Finn M, Franklin A.

Appl Environ Microbiol. 2002 Aug;68(8):4127-9.

38.

Wound infection with Neisseria weaveri and a novel subspecies of pasteurella multocida in a child who sustained a tiger bite.

Capitini CM, Herrero IA, Patel R, Ishitani MB, Boyce TG.

Clin Infect Dis. 2002 Jun 15;34(12):E74-6. Epub 2002 May 24.

PMID:
12032914
39.

Late liver function with graft obtained from donors above 65 years.

Regueira FM, Diez-Caballero A, Herrero I, Rotellar F, Hernández Lizoáin JL, Quiroga J, Pardo F, Cienfuegos JA.

Transplant Proc. 2002 Feb;34(1):231-2. No abstract available.

PMID:
11959259
40.

Effect of the platelet-activating factor antagonist BN-52021 on liver preservation (4 degrees): experimental study in isolated reperfused rat liver model.

Castellvi J, Borobia FG, Figueras J, Fradera R, Herrero I, Torras J, Busquets J, Fabregat J, Jorba R, Jaurrieta E.

Transplant Proc. 2002 Feb;34(1):50-2. No abstract available.

PMID:
11959181
41.

The ether phospholipids trail: blood timing in renal ischemia-reperfusion injury.

Lloberas N, Torras J, Herrero I, Cruzado JM, Riera M, Grinyó JM.

Transplant Proc. 2002 Feb;34(1):47-8. No abstract available.

PMID:
11959179
42.

Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium.

Herrero IA, Issa NC, Patel R.

N Engl J Med. 2002 Mar 14;346(11):867-9. No abstract available.

43.

Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences.

Thomson MM, Delgado E, Herrero I, Villahermosa ML, Vázquez-de Parga E, Cuevas MT, Carmona R, Medrano L, Pérez-Alvarez L, Cuevas L, Nájera R.

J Gen Virol. 2002 Jan;83(Pt 1):107-19.

PMID:
11752707
44.

The enhancement of endogenous cAMP with pituitary adenylate cyclase-activating polypeptide protects rat kidney against ischemia through the modulation of inflammatory response.

Riera M, Torras J, Cruzado JM, Lloberas N, Liron J, Herrero I, Navarro MA, Grinyo JM.

Transplantation. 2001 Oct 15;72(7):1217-23.

PMID:
11602845
45.

HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users.

Thomson MM, Delgado E, Manjón N, Ocampo A, Villahermosa ML, Mariño A, Herrero I, Cuevas MT, Vázquez-de Parga E, Pérez-Alvarez L, Medrano L, Taboada JA, Nájera R; Spanish Group for Antiretroviral Studies in Galicia.

AIDS. 2001 Mar 9;15(4):509-16.

PMID:
11242148
46.

Prevalence of drug resistance mutations in B, non-B subtypes, and recombinant forms of human immunodeficiency virus type 1 in infected individuals in Spain (Galicia).

Pérez-Alvarez L, Cuevas MT, Villahermosa ML, Pedreira JD, Manjón N, Herrero I, López-Calvo S, Delgado E, de Parga EV, Medrano L, Thomson MM, Taboada JA, Nájera R; Spanish Group for Antiretroviral Resistance Studies in Galicia.

J Hum Virol. 2001 Jan-Feb;4(1):35-8. No abstract available.

PMID:
11213931
47.

Prevalence of vancomycin-resistant Enterococcus faecium (VREF) in pig faeces from slaughterhouses in Spain.

Herrero IA, Teshager T, Garde J, Moreno MA, Domínguez L.

Prev Vet Med. 2000 Dec 8;47(4):255-62.

PMID:
11087956
48.

Influence of nephron mass in development of chronic renal failure after prolonged warm renal ischemia.

Cruzado JM, Torras J, Riera M, Herrero I, Hueso M, Espinosa L, Condom E, Lloberas N, Bover J, Alsina J, Grinyó JM.

Am J Physiol Renal Physiol. 2000 Aug;279(2):F259-69.

49.

Surveillance of antimicrobial resistance in Escherichia coli strains isolated from pigs at Spanish slaughterhouses.

Teshager T, Herrero IA, Porrero MC, Garde J, Moreno MA, Domínguez L.

Int J Antimicrob Agents. 2000 Jul;15(2):137-42.

PMID:
10854810
50.

Antibiotic resistance monitoring: the Spanish programme. The VAV Network. Red de Vigilancia de Resistencias Antibióticas en Bacterias de Origen Veterinario.

Moreno MA, Domínguez L, Teshager T, Herrero IA, Porrero MC.

Int J Antimicrob Agents. 2000 May;14(4):285-90.

PMID:
10794948

Supplemental Content

Loading ...
Support Center